Found 2
pulmonary-allergy-and-critical-care trials
A listing of pulmonary-allergy-and-critical-care medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This study is an exploratory, two-part, 12-week, Phase 2a study to evaluate the mechanism of action of itepekimab (anti-IL-33-mAb) and its impact on airway inflammation in former and current smokers with COPD.
To assess the effect of nintedanib on preserving L-PF measured symptom levels (cough, dyspnea, energy), impacts of disease, and quality of life in patients with MA-ILD who are also receiving SOC treatment. To assess the effect of nintedanib on preserving L-PF measured symptom levels (cough, dyspnea, energy), impacts of disease, …